Company name: Procannmed
Description: Producer of tetrahydrocannabinol and cannabidiol medical cannabis in Colombia. The company’s registered 23 high-potency THC strains and one 19.6% CBD/0.03% THC strain enables them to cultivate, extract and distribute a wide range cannabis varieties as well as develop a complete offering of standardized medicinal grade formulations.
Industry: Healthcare | Group: Healthcare Services | Code:
State: Department Of Antioquia
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Beleave (CNSX: BE) for $2.4 million on June 21, 2018.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 4.70
Last known valuation date: 21-Jun-2018